5 articles
This article analyses regulatory data protection in India under TRIPS and domestic law. It discusses the balance between originator protection and access to generic medicines, highlighting the implications…
Maldives does not yet have a formal trademark registration system, relying instead on cautionary notices for brand protection. Current legislative efforts are expected to introduce a comprehensive trademark…
This post examines the ongoing India US patent dispute, focusing on TRIPS compliance and contentious issues in pharmaceutical and software patents. It analyses whether US pressure may result…
The Supreme Court’s Novartis judgment clarified Section 3d and its application to pharmaceutical patents in India. It emphasised the need for enhanced therapeutic efficacy and outlined critical standards…
This analysis addresses the uncertain legal landscape for gene patents in India, with a focus on isolated and purified gene sequences. The author calls for clearer guidelines and…